Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates an accessibility issue rather than a substantive content update, leaving the page in an error state.SummaryDifference17%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.6.6 is now shown, replacing v3.6.5. This indicates an internal page or template update rather than any changes to the study details, eligibility criteria, or results.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, signaling a minor deployment update to the page. This update does not alter the study details or other content.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page's revision label updated from v3.6.3 to v3.6.4, indicating a new build/maintenance update of the ClinicalTrials.gov page. This update does not alter the study content or data displayed.SummaryDifference0.1%

- Check92 days agoChange DetectedFooter revision tag updated from v3.6.2 to v3.6.3, indicating a minor page update. No study information or functionality is affected.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page now displays a newer revision tag (v3.6.2) replacing the previous v3.6.0, indicating a software/system update for the page.SummaryDifference0.1%

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.